IperionX Limited Sponsored ADR (NASDAQ:IPX – Get Free Report) Chairman Todd Hannigan purchased 300,000 shares of the business’s stock in a transaction that occurred on Monday, July 13th. The shares were bought at an average price of $3.59 per share, for a total transaction of $1,077,000.00. Following the completion of the purchase, the chairman directly owned 26,633,334 shares in the company, valued at $95,613,669.06. This represents a 1.14% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.
Todd Hannigan also recently made the following trade(s):
- On Friday, July 10th, Todd Hannigan bought 225,000 shares of IperionX stock. The shares were purchased at an average price of $3.58 per share, for a total transaction of $805,500.00.
- On Tuesday, April 28th, Todd Hannigan bought 220,000 shares of IperionX stock. The stock was purchased at an average cost of $4.48 per share, with a total value of $985,600.00.
- On Wednesday, April 29th, Todd Hannigan purchased 260,000 shares of IperionX stock. The shares were purchased at an average price of $4.20 per share, for a total transaction of $1,092,000.00.
IperionX Trading Down 1.4%
IPX opened at $24.67 on Tuesday. IperionX Limited Sponsored ADR has a 52 week low of $21.66 and a 52 week high of $61.45. The business’s 50 day moving average is $34.10 and its two-hundred day moving average is $37.43. The company has a quick ratio of 4.00, a current ratio of 4.03 and a debt-to-equity ratio of 0.03.
Institutional Trading of IperionX
Wall Street Analysts Forecast Growth
A number of research analysts have commented on the stock. Weiss Ratings restated a “sell (e+)” rating on shares of IperionX in a research note on Tuesday, April 21st. Roth Capital reiterated a “buy” rating on shares of IperionX in a research note on Monday, June 8th. BTIG Research boosted their price target on IperionX from $40.00 to $55.00 and gave the company a “buy” rating in a research report on Friday, June 5th. Finally, Alliance Global Partners reaffirmed a “buy” rating on shares of IperionX in a research report on Tuesday, April 28th. Five analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat.com, IperionX currently has a consensus rating of “Moderate Buy” and an average target price of $60.33.
Read Our Latest Stock Analysis on IPX
About IperionX
IperionX (NASDAQ: IPX) is a mineral technology company focused on the production and commercialization of high‐purity titanium and zirconium products. The company’s core activities include the development of advanced mineral sands projects and the deployment of proprietary processing technologies aimed at supplying feedstocks to aerospace, defense, additive manufacturing and battery markets.
At the heart of IperionX’s operations is the Stony Creek Project in Virginia, where the company holds significant mineral sands rights.
Featured Stories
- Five stocks we like better than IperionX
- The SK Hynix IPO and 2027’s AI Memory Squeeze
- Meta Platforms Stock Rises as Muse Spark 1.1 AI Model Debuts
- Why Welltower’s Growth Story Might Outrun Its Rich Valuation
- One Short- and One Long-Term ETF for Quantum Computing Bulls
Receive News & Ratings for IperionX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IperionX and related companies with MarketBeat.com's FREE daily email newsletter.
